Atlas Trials

Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

Clinical trial NCT04610671 · COMPLETED

Trial details

NCT number
NCT04610671
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Muscle-Invasive Bladder CarcinomaBladder Cancer
Start date
2020-10-26
Primary completion
2024-07-25
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.